Literature DB >> 34989720

Detailed structural and spectroscopic elucidation of ferrocenium coupled N-heterocyclic carbene gold(I) complexes.

Garrett L Reinhard1, Selvakumar Jayaraman1, Joshua W Prybil2, Jonathan F Arambula3, Kuppuswamy Arumugam1.   

Abstract

Unambiguous assignment of redox sites on ferrocene coupled N-heterocyclic carbene gold(I) complexes [(Fc-NHC)2Au(I)]+ is critical to gain a greater mechanistic understanding of their activity in a cellular environment. Such information can be garnered with isolation and detailed characterization of the oxidized version of [(Fc-NHC)2Au(I)]+. Herein we disclose a study that unambiguously illustrates redox events pertaining to [(Fc-NHC)2Au(I)]+ that stem exclusively from ferrocene sites. This work also describes novel synthetic methodologies for isolating ferrocenium coupled N-heterocyclic carbene gold(I) complexes.

Entities:  

Year:  2022        PMID: 34989720      PMCID: PMC9069980          DOI: 10.1039/d1dt03174k

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.569


  25 in total

1.  Gold-based therapeutic agents.

Authors:  C F Shaw III
Journal:  Chem Rev       Date:  1999-09-08       Impact factor: 60.622

Review 2.  Texaphyrins: tumor localizing redox active expanded porphyrins.

Authors:  Jonathan F Arambula; Christian Preihs; Derric Borthwick; Darren Magda; Jonathan L Sessler
Journal:  Anticancer Agents Med Chem       Date:  2011-02       Impact factor: 2.505

3.  Anticancer activity of heteroleptic diimine complexes of dirhodium: a study of intercalating properties, hydrophobicity and in cellulo activity.

Authors:  J Dafhne Aguirre; Alfredo M Angeles-Boza; Abdellatif Chouai; Claudia Turro; Jean-Philippe Pellois; Kim R Dunbar
Journal:  Dalton Trans       Date:  2009-10-30       Impact factor: 4.390

Review 4.  Targeting survivin in cancer.

Authors:  Dario C Altieri
Journal:  Cancer Lett       Date:  2012-03-09       Impact factor: 8.679

5.  Preparation and isolation of dithiolene thiophosphoryl molecules as stable, protected forms of dithiolene ligands.

Authors:  Kuppuswamy Arumugam; James E Bollinger; Mark Fink; James P Donahue
Journal:  Inorg Chem       Date:  2007-03-15       Impact factor: 5.165

Review 6.  Metals and metal compounds in cancer treatment.

Authors:  Bernard Desoize
Journal:  Anticancer Res       Date:  2004 May-Jun       Impact factor: 2.480

Review 7.  Particular aspects of platinum compounds used at present in cancer treatment.

Authors:  Bernard Desoize; Claudie Madoulet
Journal:  Crit Rev Oncol Hematol       Date:  2002-06       Impact factor: 6.312

Review 8.  Anticancer activity of metal complexes: involvement of redox processes.

Authors:  Ute Jungwirth; Christian R Kowol; Bernhard K Keppler; Christian G Hartinger; Walter Berger; Petra Heffeter
Journal:  Antioxid Redox Signal       Date:  2011-05-11       Impact factor: 8.401

9.  Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin.

Authors:  Sarah D Brown; Paola Nativo; Jo-Ann Smith; David Stirling; Paul R Edwards; Balaji Venugopal; David J Flint; Jane A Plumb; Duncan Graham; Nial J Wheate
Journal:  J Am Chem Soc       Date:  2010-04-07       Impact factor: 15.419

Review 10.  Organometallic anticancer compounds.

Authors:  Gilles Gasser; Ingo Ott; Nils Metzler-Nolte
Journal:  J Med Chem       Date:  2010-11-15       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.